[go: up one dir, main page]

FR2917623B1 - Utilisation d'un probiotique pour la prevention des infections des voies respiratoires - Google Patents

Utilisation d'un probiotique pour la prevention des infections des voies respiratoires

Info

Publication number
FR2917623B1
FR2917623B1 FR0704506A FR0704506A FR2917623B1 FR 2917623 B1 FR2917623 B1 FR 2917623B1 FR 0704506 A FR0704506 A FR 0704506A FR 0704506 A FR0704506 A FR 0704506A FR 2917623 B1 FR2917623 B1 FR 2917623B1
Authority
FR
France
Prior art keywords
probiotic
prevention
respiratory infections
infections
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0704506A
Other languages
English (en)
Other versions
FR2917623A1 (fr
Inventor
Gerard Lacoste
Hubert Desjonqueres
Stephane Patrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lyoct SA Lab
Original Assignee
Lyoct SA Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyoct SA Lab filed Critical Lyoct SA Lab
Priority to FR0704506A priority Critical patent/FR2917623B1/fr
Publication of FR2917623A1 publication Critical patent/FR2917623A1/fr
Application granted granted Critical
Publication of FR2917623B1 publication Critical patent/FR2917623B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0704506A 2007-06-22 2007-06-22 Utilisation d'un probiotique pour la prevention des infections des voies respiratoires Expired - Fee Related FR2917623B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0704506A FR2917623B1 (fr) 2007-06-22 2007-06-22 Utilisation d'un probiotique pour la prevention des infections des voies respiratoires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0704506A FR2917623B1 (fr) 2007-06-22 2007-06-22 Utilisation d'un probiotique pour la prevention des infections des voies respiratoires

Publications (2)

Publication Number Publication Date
FR2917623A1 FR2917623A1 (fr) 2008-12-26
FR2917623B1 true FR2917623B1 (fr) 2009-10-09

Family

ID=39030987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0704506A Expired - Fee Related FR2917623B1 (fr) 2007-06-22 2007-06-22 Utilisation d'un probiotique pour la prevention des infections des voies respiratoires

Country Status (1)

Country Link
FR (1) FR2917623B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
FR3114970B1 (fr) * 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180260A1 (en) * 2000-06-19 2003-09-25 Clancy Robert Llewellyn Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
FR2889958A1 (fr) * 2005-08-25 2007-03-02 Lyoct Sa Lab Utilisation d'un symbiotique pour le traitement de la dermatite atopique

Also Published As

Publication number Publication date
FR2917623A1 (fr) 2008-12-26

Similar Documents

Publication Publication Date Title
BRPI0809787A2 (pt) "respirador isento de manutenção"
BRPI0809898A2 (pt) "respirador isento de manutenção"
SMAP200900055A (it) Chinazoline per l'inibizione di pdk1
SMP200800059B (it) Chinazoline per l'inibizione di pdk1
BRPI0810646A2 (pt) " compostos farmacêuticos ".
EP2232348A4 (fr) Diagnostic pour régulation d'écoulement massique
ZA200804932B (en) Compounds for the inhibition of integrins and use thereof
EP1901733A4 (fr) Utilisation d'huperzine pour des pathologies
ZA201009079B (en) "sulfonamide compounds or salts thereof"
FR2931071B1 (fr) Confiserie aux algues pour la prevention des infections buccodentaires
EP2402431A4 (fr) Agent pour la prévention ou l'amélioration de l'obésité
EP2079561A4 (fr) Attaches et bagues d'espacement pour celles-ci
EP2200679A4 (fr) Mécanisme d'accouplement amovible
FR2900047B1 (fr) Utilisation d'un derive diphenyl-methane pour le soin des peaux grasses
EP2311472A4 (fr) Agent pour l' amélioration des troubles cognitifs
FR2915400B1 (fr) Element en y pour systemes medicaux d'assistance respiratoire
EP2308860A4 (fr) Immunosuppresseur fondé sur l'interruption de l'interaction tcr-nck
FR2917623B1 (fr) Utilisation d'un probiotique pour la prevention des infections des voies respiratoires
EP2007372A4 (fr) Agents d'administration des éthers dialkyliques
EP2484379A4 (fr) Agent pour la prévention de l'athérosclérose
GB0724282D0 (en) The 'opbric' system
EP2452949A4 (fr) Utilisation d'anhydrase carbonique ii pour la préparation d'un médicament
GB2451897B (en) "No-bend" pet-feeding aid
ITMO20070046A1 (it) "apparato per l' essicazione di materiali, particolarmente zeoliti o simili"
FR2946534B1 (fr) Utilisation d'alkylglycerols pour la preparation de medicaments.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110228